Cambridge Research Biochemicals Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cambridge Research Biochemicals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011806
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cambridge Research Biochemicals Ltd (CRB) is a provider of custom peptide and custom antibody producer for research activities. The company offers products such as stock peptides, peptide nucleic acid, florescent dyes, and immunological products and labeling kits. Its immunological products and labeling kits comprise europium protein labeling kits, QRET assay kits, chromis DGE kits, ECL reagents and synthetic haptens: NP and NIP products. The company offers services such as peptide synthesis, antibody production, dye labeling, peptide conjugates, PNA synthesis, and specialty peptide services. It also provides partnerships with pharmaceutical, biotechnology and research institutes. CRB is headquartered in Billingham, the UK.

Cambridge Research Biochemicals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cambridge Research Biochemicals Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AssayMetrics Enters Into Agreement With Cambridge Research Biochemicals 10
Licensing Agreements 11
Cambridge Research Biochemicals Enters Into Licensing Agreement With Medical Research Council 11
Cambridge Research Biochemicals Enters Into Licensing Agreement With Li-Cor Biosciences For Infrared Dye-Labeled Peptides 12
Cambridge Research Biochemicals Extends Licensing Agreement With Life Technologies 13
Cambridge Research Biochemicals Ltd – Key Competitors 14
Cambridge Research Biochemicals Ltd – Key Employees 15
Cambridge Research Biochemicals Ltd – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Aug 16, 2016: Cambridge Research Biochemicals Launches New Discovery Peptides Catalogue to the Life Science Community 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cambridge Research Biochemicals Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Cambridge Research Biochemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AssayMetrics Enters Into Agreement With Cambridge Research Biochemicals 10
Cambridge Research Biochemicals Enters Into Licensing Agreement With Medical Research Council 11
Cambridge Research Biochemicals Enters Into Licensing Agreement With Li-Cor Biosciences For Infrared Dye-Labeled Peptides 12
Cambridge Research Biochemicals Extends Licensing Agreement With Life Technologies 13
Cambridge Research Biochemicals Ltd, Key Competitors 14
Cambridge Research Biochemicals Ltd, Key Employees 15

★海外企業調査レポート[Cambridge Research Biochemicals Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Eurofins Scientific SE (ERF):企業の財務・戦略的SWOT分析
    Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Proton Holdings Berhad:企業の戦略的SWOT分析
    Proton Holdings Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Phillips 66 Co (PSX):石油・ガス:M&Aディール及び事業提携情報
    Summary Phillips 66 Co (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports, stores and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants. It also transports, fractionates and markets natural gas …
  • Ework Group AB (EWRK):企業の財務・戦略的SWOT分析
    Ework Group AB (EWRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aalborg Portland Holding A/S:企業の戦略・SWOT・財務情報
    Aalborg Portland Holding A/S - Strategy, SWOT and Corporate Finance Report Summary Aalborg Portland Holding A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • General Re Corporation:企業の戦略・SWOT・財務情報
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • KPIT Technologies Ltd (BSOFT):企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mehler Vario System GmbH:企業の戦略・SWOT・財務情報
    Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report Summary Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Malaysia Airlines Berhad:企業の戦略・SWOT・財務情報
    Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report Summary Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Questor Technology Inc (QST):企業の財務・戦略的SWOT分析
    Questor Technology Inc (QST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Aegean Airlines S.A.:企業の戦略・SWOT・財務情報
    Aegean Airlines S.A. - Strategy, SWOT and Corporate Finance Report Summary Aegean Airlines S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Soligenix Inc (SNGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymph …
  • In-N-Out Burgers:企業の戦略・SWOT・財務情報
    In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report Summary In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆